Biond Biologics
PrivateLast Round
Strategic
Jun 1, 2026
Total Funding Raised
$40M
Company Overview
Biond Biologics is a biotechnology company that develops first-in-class immunotherapies for the treatment of cancer and immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biond Biologics Comparables
Compare Biond Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tizona Therapeutics | 80% | |
| Compugen Ltd. | 79% | |
| Invectys | 78% | |
Biond Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 1, 2026 | ||||
| Series C | Nov 3, 2021 | ||||
| Series B | Jan 8, 2019 |
Key People
Founding team and executive leadership
Biond Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Series B |
| Deep Insight | Series C |
| The Heritage Group | Series C |
| SBI JI | Series B |
| Harel Insurance Investments & Financial Services | Series C, Series B |
Biond Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biond Biologics's valuation, stock price, and market status.